High Coffee Consumption Correlated with Reduced Liver Disease Risk
A large-scale study links drinking five or more cups of coffee daily to significantly lower risks of liver cancer, cirrhosis, and liver mortality.
Atlas Newsdesk ·
A longitudinal study of 355,000 adults indicates that daily consumption of five or more cups of coffee is associated with a 50% reduction in liver cancer risk. Data also show a 32% lower risk of cirrhosis and a 42% decrease in liver-related mortality compared to non-consumers.
Researchers utilized MRI imaging and blood proteomic analysis to identify biological markers supporting these clinical outcomes. Findings suggest that coffee intake correlates with reduced liver fat, lower inflammation, and improved fibrosis-related biomarkers.
Analysis indicates that both caffeinated and decaffeinated coffee
Analysis indicates that both caffeinated and decaffeinated coffee provide similar protective effects, suggesting that non-caffeine bioactive compounds are the primary drivers of these health benefits. These compounds appear to mitigate oxidative stress and improve metabolic function.
While the study establishes a dose-response relationship, it does not confirm direct causation. These findings provide evidence for potential public health strategies regarding liver disease prevention through dietary intervention.